| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 74.77▲ | 74.58▲ | 74.50▲ | 74.66▲ | 73.83▲ |
| MA10 | 74.67▲ | 74.63▲ | 74.49▲ | 74.46▲ | 71.32▲ |
| MA20 | 74.53▲ | 74.48▲ | 74.12▲ | 73.70▲ | 71.89▲ |
| MA50 | 74.57▲ | 74.08▲ | 74.09▲ | 69.97▲ | 63.39▲ |
| MA100 | 74.62▲ | 74.05▲ | 74.57▲ | 72.58▲ | 40.32▲ |
| MA200 | 74.10▲ | 74.41▲ | 72.07▲ | 64.26▲ | 29.26▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.063▲ | 0.002▲ | 0.113▲ | -0.201▼ | -0.095▼ |
| RSI | 60.776▲ | 55.619▲ | 54.431▲ | 56.783▲ | 57.421▲ |
| STOCH | 76.761 | 25.459 | 47.951 | 59.446 | 80.225▲ |
| WILL %R | -13.291▲ | -52.053 | -30.736 | -33.531 | -9.827▲ |
| CCI | 122.714▲ | 7.653 | 63.602 | 48.763 | 90.154 |
|
Tuesday, August 25, 2026 05:30 AM
Nektar Therapeutics (Nasdaq: NKTR) today announced the publication of peer-reviewed data from the 16-week induction period of REZOLVE-AD, a global, randomized, double-blind, placebo-controlled Phase ...
|
|
Friday, August 21, 2026 04:32 AM
Detailed price information for Nektar Therapeutics (NKTR-Q) from The Globe and Mail including charting and trades.
|
|
Saturday, August 15, 2026 07:12 AM
Detailed price information for Nektar Therapeutics (NKTR-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/08/26 | 74.98 | 76.79 | 74.06 | 74.96 | 411,855 |
| 24/08/26 | 73.975 | 74.345 | 70.925 | 73.69 | 410,715 |
| 21/08/26 | 75.10 | 76.2344 | 72.825 | 74.02 | 585,337 |
| 20/08/26 | 76.08 | 76.5253 | 73.19 | 74.53 | 438,552 |
| 19/08/26 | 75.00 | 76.215 | 73.4299 | 76.08 | 701,892 |
| 18/08/26 | 72.00 | 74.91 | 70.48 | 73.64 | 554,094 |
| 17/08/26 | 72.09 | 74.80 | 70.505 | 72.67 | 676,076 |
| 14/08/26 | 74.00 | 75.75 | 72.05 | 73.02 | 828,321 |
| 13/08/26 | 76.40 | 77.22 | 75.45 | 75.92 | 609,651 |
| 12/08/26 | 75.99 | 76.74 | 75.42 | 76.03 | 542,796 |
|
|
||||
|
|
||||
|
|